The Steering Group consists of a total of 10 members: Each of the five partnering universities appoints one high-level representative. Similarly, one high-level representative is appointed from four of the initial 13 core industry partners. One representative is included from the pharma industry association Lægemiddelindustriforeningen (Lif).
You can read more about the review organs on our website or contact us for more information.
Poul Nissen, AU
Vice-Dean for Research
Trine Winterø, KU
Vice Dean for Innovation at the Faculty of Health and Medical Sciences
Jakob Møller-Jensen, SDU
Head of the Department of Biochemistry and Molecular Biology
Rolf Henrik Berg, DTU
Head of Innovation at DTU Health Tech
Pacsal Madeleine, AAU
Director of the Doctoral School in Medicine, Biomedical Science, and Technology
Emma Fountain, Bayer
VP, R&D Projects and Operations Cluster Lead
Thomas Poulsen, Mmimetika
Co-Founder and CTO
Anders Hoff, LIF
Head of Research and Innovation Policy, Danish Association of the Pharmaceutical Industry
ABOUT ODIN
We unite bright minds from industry and academia to jointly create need-driven clinical research projects - and pave the way for innovative new treatments and diagnostics. We fund the best project ideas through competitive funding calls. Although companies cannot receive funding, it is free of charge to join.
The platform is sponsored by the Novo Nordisk Foundation with 180 million DKK from 2024-2029.
CONTACT ODIN
You are welcome to contact us if you have questions or comments. Reach out to odin@au.dk or find the Secretariat's direct email addresses under contacts.
Although the platform spans five Danish universities, we're based in Aarhus. Our office is located at Aarhus University, Ny Munkegade 116, Bldg 1535-117.
